Net Cash Provided by (Used in) Financing Activities of LIFECORE BIOMEDICAL, INC. \DE\ from 30 May 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
LIFECORE BIOMEDICAL, INC. \DE\ quarterly and annual Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 30 May 2010 to 30 Sep 2025.
  • LIFECORE BIOMEDICAL, INC. \DE\ Net Cash Provided by (Used in) Financing Activities for the quarter ending 30 Sep 2025 was $1,388,000, a 227% decline year-over-year.
  • LIFECORE BIOMEDICAL, INC. \DE\ annual Net Cash Provided by (Used in) Financing Activities for 2024 was $6,424,000, a 14% decline from 2023.
  • LIFECORE BIOMEDICAL, INC. \DE\ annual Net Cash Provided by (Used in) Financing Activities for 2023 was $7,509,000, a 81% decline from 2022.
  • LIFECORE BIOMEDICAL, INC. \DE\ annual Net Cash Provided by (Used in) Financing Activities for 2022 was $39,700,000.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

LIFECORE BIOMEDICAL, INC. \DE\ Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $1,388,000 -$2,481,000 -227% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025 2026 Q1
Q3 2024 $1,093,000 -$1,841,000 -63% 27 May 2024 25 Aug 2024 10-Q 06 Nov 2025 2026 Q1
Q3 2023 $2,934,000 -$972,000 -25% 29 May 2023 27 Aug 2023 10-Q 04 Oct 2024 2025 Q1
Q3 2022 $3,906,000 +$42,854,000 30 May 2022 28 Aug 2022 10-Q 09 Aug 2024 2024 Q1
Q3 2021 $38,948,000 -$21,924,000 -129% 31 May 2021 29 Aug 2021 10-K 20 Mar 2024 2023 FY
Q3 2020 $17,024,000 -$33,039,000 -206% 01 Jun 2020 30 Aug 2020 10-K 20 Mar 2024 2023 FY
Q3 2019 $16,015,000 +$5,296,000 +49% 27 May 2019 25 Aug 2019 10-Q 07 Oct 2020 2021 Q1
Q3 2018 $10,719,000 +$4,518,000 +73% 28 May 2018 26 Aug 2018 10-Q 03 Oct 2019 2020 Q1
Q3 2017 $6,201,000 29 May 2017 27 Aug 2017 10-Q 05 Oct 2018 2019 Q1
Q3 2013 $5,262,000 +$9,166,000 +64% 27 May 2013 25 Aug 2013 10-Q 26 Sep 2013 2014 Q1
Q3 2012 $14,428,000 -$14,726,000 -4942% 28 May 2012 26 Aug 2012 10-Q 26 Sep 2013 2014 Q1
Q3 2011 $298,000 +$457,000 30 May 2011 28 Aug 2011 10-Q/A 02 Jan 2013 2013 Q1
Q3 2010 $159,000 01 Jun 2010 29 Aug 2010 10-Q 05 Oct 2011 2012 Q1

LIFECORE BIOMEDICAL, INC. \DE\ Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $6,424,000 -$1,085,000 -14% 27 May 2024 25 May 2025 10-KT 16 Mar 2026 2025 FY
2023 $7,509,000 -$32,191,000 -81% 29 May 2023 26 May 2024 10-KT 16 Mar 2026 2025 FY
2022 $39,700,000 +$96,721,000 30 May 2022 28 May 2023 10-K 26 Aug 2024 2024 FY
2021 $57,021,000 -$53,602,000 -1568% 31 May 2021 29 May 2022 10-K 26 Aug 2024 2024 FY
2020 $3,419,000 -$43,436,000 -109% 01 Jun 2020 30 May 2021 10-K 20 Mar 2024 2023 FY
2019 $40,017,000 -$39,009,000 -49% 27 May 2019 31 May 2020 10-K/A 16 Mar 2023 2022 FY
2018 $79,026,000 +$65,734,000 +495% 28 May 2018 26 May 2019 10-K 29 Jul 2021 2021 FY
2017 $13,292,000 +$22,093,000 29 May 2017 27 May 2018 10-K 14 Aug 2020 2020 FY
2016 $8,801,000 -$24,224,000 -157% 30 May 2016 28 May 2017 10-K 01 Aug 2019 2019 FY
2015 $15,423,000 01 Jun 2015 29 May 2016 10-K 09 Aug 2018 2018 FY
2012 $19,267,000 -$55,201,000 -154% 28 May 2012 26 May 2013 10-K 07 Aug 2013 2013 FY
2011 $35,934,000 +$40,698,000 30 May 2011 27 May 2012 10-K 07 Aug 2013 2013 FY
2010 $4,764,000 -$24,436,000 -124% 31 May 2010 29 May 2011 10-K 07 Aug 2013 2013 FY
2009 $19,672,000 01 Jun 2009 30 May 2010 10-K 08 Aug 2012 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.